Pulmicort

Budesonide 200mcg
(Brand) Astra
1200 doses
inhalar
74 €Buy Now

Singulair

asthma
Montelukast sodium 5mg
(Brand) MSD
28Tablets82 €Buy Now
Montelukast sodium 10mg
(Brand) MSD
28Tablets87 €Buy Now

Foradil

Foranoterol fumerate
12mcg/cap (Brand) Novartis
60CapsInhalation-caps78 €Buy Now

Serevent

Salmetrol 25mcg/dose
(Brand) GSK
1200 doses
inhalar
65 €Buy Now
Salmetrol diskus
50mcg/dose (Brand) GSK
60Inhalation
caps
69 €Buy Now

Seretide

50/250 (Brand) GSK1Inhalar78 €Buy Now
50/500 (Brand) GSK1Inhalar87 €Buy Now

Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and COPD. Formoterol has an extended duration of action (up to 12 h) compared to short-acting β2 agonists such as salbutamol (albuterol), which are effective for 4 h to 6 h. LABAs such as formoterol are used as “symptom controllers” to supplement prophylactic corticosteroid therapy. A “reliever” short-acting β2 agonist (e.g., salbutamol) is still required, since LABAs are not recommended for the treatment of acute asthma

n November 2005, the US FDA released a health advisory alerting the public to findings that show the use of long-acting β2 agonists could lead to a worsening of wheezing symptoms in some patients.[2]

At the current time, available long-acting β2 agonists include salmeterol, formoterol, bambuterol, and sustained-release oral salbutamol.

Combinations of inhaled steroids and long-acting bronchodilators are becoming more widespread – combination preparations include fluticasone/salmeterol and budesonide/formoterol